From Alzheimer's disease to skin tumors: the catenin connection.
Hartmann
D
D
Neuronal Cell Biology Laboratory, Center for Human Genetics, Flanders Interuniversity Institute for Biotechnology, and Catholic University of Leuven, Campus Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. Dieter.Hartmann@med.kuleuven.ac.be
D000544:Alzheimer Disease / Q000378:metabolism*; D000818:Animals; D019938:Cyclin D1 / Q000378:metabolism*; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D004268:DNA-Binding Proteins / Q000378:metabolism*; D051821:Lymphoid Enhancer-Binding Factor 1; D008565:Membrane Proteins / Q000235:genetics / Q000502:physiology*; D051379:Mice; D053764:Presenilin-1; D015398:Signal Transduction; D012878:Skin Neoplasms / Q000378:metabolism*; D015534:Trans-Activators; D014157:Transcription Factors / Q000378:metabolism*; D051176:beta Catenin
C495267:CTNNB1 protein, mouse; D003598:Cytoskeletal Proteins; D004268:DNA-Binding Proteins; D051821:Lymphoid Enhancer-Binding Factor 1; D008565:Membrane Proteins; D053764:Presenilin-1; D015534:Trans-Activators; D014157:Transcription Factors; D051176:beta Catenin; D019938:Cyclin D1